A failed clinical trial can erase billions in market value in the pharmaceutical industry. Conversely, a breakthrough drug can potentially establish a company as a Fortune 500 giant almost overnight.
The sector that brought us lifesaving vaccines and revolutionary cancer treatments also leaves a trail of bankrupt companies and shattered portfolios in its wake.
This article will dissect the major risk factors that every pharmaceutical investor must understand.




